AUGMENTIN Drug Patent Profile
✉ Email this page to a colleague
When do Augmentin patents expire, and when can generic versions of Augmentin launch?
Augmentin is a drug marketed by Us Antibiotics and is included in eight NDAs.
The generic ingredient in AUGMENTIN is amoxicillin; clavulanate potassium. There are forty-six drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Augmentin
A generic version of AUGMENTIN was approved as amoxicillin; clavulanate potassium by SANDOZ on March 14th, 2002.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AUGMENTIN?
- What are the global sales for AUGMENTIN?
- What is Average Wholesale Price for AUGMENTIN?
Summary for AUGMENTIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 8 |
| Drug Prices: | Drug price information for AUGMENTIN |
| Drug Sales Revenues: | Drug sales revenues for AUGMENTIN |
| What excipients (inactive ingredients) are in AUGMENTIN? | AUGMENTIN excipients list |
| DailyMed Link: | AUGMENTIN at DailyMed |



